Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001437749-16-035895
Filing Date
2016-07-29
Accepted
2016-07-28 18:24:47
Documents
60
Period of Report
2016-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q acrx20160630_10q.htm 10-Q 1487958
2 EXHIBIT 10.3 ex10-3.htm EX-10.3 2823
3 EXHIBIT 31.1 ex31-1.htm EX-31.1 9874
4 EXHIBIT 31.2 ex31-2.htm EX-31.2 10072
5 EXHIBIT 32.1 ex32-1.htm EX-32.1 7815
12 a3.jpg GRAPHIC 67490
13 a2.jpg GRAPHIC 65752
14 a1.jpg GRAPHIC 160017
  Complete submission text file 0001437749-16-035895.txt   5870777

Data Files

Seq Description Document Type Size
6 EXHIBIT 101.INS acrx-20160630.xml EX-101.INS 1034277
7 EXHIBIT 101.SCH acrx-20160630.xsd EX-101.SCH 57861
8 EXHIBIT 101.CAL acrx-20160630_cal.xml EX-101.CAL 36968
9 EXHIBIT 101.DEF acrx-20160630_def.xml EX-101.DEF 322114
10 EXHIBIT 101.LAB acrx-20160630_lab.xml EX-101.LAB 310171
11 EXHIBIT 101.PRE acrx-20160630_pre.xml EX-101.PRE 339316
Mailing Address 351 GALVESTON DRIVE REDWOOD CITY CA 94063
Business Address 351 GALVESTON DRIVE REDWOOD CITY CA 94063 650-216-3500
ACELRX PHARMACEUTICALS INC (Filer) CIK: 0001427925 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35068 | Film No.: 161791430
SIC: 2834 Pharmaceutical Preparations